Cure from breast cancer, not quite yet but getting there?

Vascular closure device failure: we are getting better but not there yet.

Preprescription genotyping: not yet ready for prime time, but getting there.

There are few, if any, situations in medicine in which a clinician can predict with certainty an individual’s response to drug therapy. A host of factors can modulate this response: concomitant disease or drug therapy, sex, age, ethnicity, or dysfunction of excretory organs, to name but a few. Even when we correct for changes anticipated by such conditions, however, drug responses remain highly...

Obesity: knowledge, care, and commitment, but not yet cure.

The management of obesity is a major public health and economic global concern. Few diseases or conditions are as common or have the health implications of obesity. Although obesity can be simply defined as a disorder of excess body fat, the major pathobiology occurs in other tissues such as hepatic, vascular system, musculoskeletal, etc (1). Obesity is undoubtedly an important risk factor for ...

Breast Cancer Vaccine: Are We There Yet?

In lieu of an abstract, here is the article's first paragraph: Breast cancer is the most fatal form of cancer for female population worldwide. National Cancer Institute (NCI) estimates 226,870 females and 2,190 males to be diagnosed with breast cancer in the United States by the end of 2012. The estimated death toll for this year includes 39,510 females and 410 males, as reported by NCI. Statis...

Closer but not there yet: models in child injury research.